-
The findings of this study, which are consistent with the results of studies in animals, as well as in vitro and epidemiologic dietary studies, suggest that current levels of vitamin A supplementation and food fortification in many Western countries may need to be reassessed.
-
The metabolic syndrome affects more than 1 in 5 Americans and is increased substantially in Mexican Americans and by several modifiable lifestyle factors.
-
Initiation of antihypertensive treatment involving ACE inhibitors in older subjects, particularly men, appears to lead to better outcomes than treatment with diuretic agents, despite similar reductions of blood pressure.
-
Eletriptan is the newest triptan to be approved for the treatment of migraine headaches. It marks the seventh entry into this crowded market.
-
Use of Hip Protectors in Nursing Homes: Cluster Randomized Controlled Trial; Disclosing Unanticipated Outcomes and Medical Errors; Non-Invasive Positive Pressure Ventilation to Treat Respiratory Failure Resulting from Exacerbations of COPD
-
-
The Bush administration may have failed in two attempts to offer a prescription drug discount plan, but that wont stop it from trying again.
-
The final security standards and transaction modifications for electronic health information are here at last.
-
Pharmacists are experts at dispensing the correct drug in the correct dosage to the correct patient. Two pharmacists, however, suggest that the profession can do a better job of considering the public, collectively, as a patient.
-
A study of long-term, low-dose warfarin (Coumadin) in the prevention of blood-clotting disorders showed such promise that the National Institutes of Health, the trials sponsor, stopped the study early.
